Oral administration of fermented wild ginseng ameliorates DSS-induced acute colitis by inhibiting NF-B signaling and protects intestinal epithelial barrier
Oral administration of fermented wild ginseng ameliorates DSS-induced acute colitis by inhibiting NF-κB signaling and protects intestinal epithelial barrier
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Ginseng has been widely used for therapeutic and preventive purposes for thousands of years. However, orally administered ginseng has very low bioavailability and absorption in the intestine. Therefore, fermented ginseng was developed to enhance the beneficial effects of ginseng in the intestine. In this study, we investigated the molecular mechanisms underlying the anti-inflammatory activity of fermented wild ginseng (FWG). We found that FWG significantly alleviated the severity of colitis in a dextran sodium sulfate (DSS)-induced colitis mouse model, and decreased expression level of pro-inflammatory cytokines in colonic tissue. Moreover, we observed that FWG suppressed the infiltration of macrophages in DSS-induced colitis. FWG also attenuated the transcriptional activity of nuclear factor-B (NF-B) by reducing the translocation of NF-B into the nucleus. Our data indicate that FWG contains anti-inflammatory activity via NF-B inactivation and could be useful for treating colitis.
Abstract
Ginseng has been widely used for therapeutic and preventive purposes for thousands of years. However, orally administered ginseng has very low bioavailability and absorption in the intestine. Therefore, fermented ginseng was developed to enhance the beneficial effects of ginseng in the intestine. In this study, we investigated the molecular mechanisms underlying the anti-inflammatory activity of fermented wild ginseng (FWG). We found that FWG significantly alleviated the severity of colitis in a dextran sodium sulfate (DSS)-induced colitis mouse model, and decreased expression level of pro-inflammatory cytokines in colonic tissue. Moreover, we observed that FWG suppressed the infiltration of macrophages in DSS-induced colitis. FWG also attenuated the transcriptional activity of nuclear factor-κB (NF-κB) by reducing the translocation of NF-κB into the nucleus. Our data indicate that FWG contains anti-inflammatory activity via NF-κB inactivation and could be useful for treating colitis.
참고문헌 (35)
- Xavier RJ, "Unravelling the pathogenesis of inflammatory bowel disease", Nature, 448, pp.427~434 (2007)
- Schwanke RC, "Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3K", Akt signaling pathway, 2013, pp.57, 1938~1949
- Ke F, "Herbal medicine in the treatment of ulcerative colitis", Saudi J Gastroenterol, 18, pp.3~10 (2012)
- Strober W, "The fundamental basis of inflammatory bowel disease", J Clin Invest, 117, pp.514~521 (2007)
- Melgar S, "Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease", Int Immunopharmacol, 8, pp.836~844 (2008)
- Solomon L, "The dextran sulphate sodium (DSS) model of colitis: an overview", Comparative Clinical Pathology, 19, pp.235~239 (2010)
- Boismenu R, "Insights from mouse models of colitis", J Leukoc Biol, 67, pp.267~278 (2000)
- Camilleri M, "Intestinal barrier function in health and gastrointestinal disease", Neurogastroenterol Motil, 24, pp.503~512 (2012)
- Suzuki T, "Regulation of intestinal epithelial permeability by tight junctions", Cell Mol Life Sci, 70, pp.631~659 (2013)
- Wong VK, "Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-kappaB signaling", J Cell Biochem, 111, pp.899~910 (2010)
- Mollah ML, "Antiobesity effects of wild ginseng(Panax ginseng C. A. Meyer)mediated by PPAR-gamma, GLUT4 and LPL in ob", ob mice, 2009, pp.23, 220~225
- Karmazyn M, "Therapeutic potential of ginseng in the management of cardiovascular disorders", Drugs, 71, pp.1989~2008 (2011)
- Lee DC, "Effects of Panax ginseng on tumor necrosis factor-alpha-mediated inflammation: a mini-review", Molecules, 16, pp.2802~2816 (2011)
- Lu JM, "Ginseng compounds: an update on their molecular mechanisms and medical applications", Curr Vasc Pharmacol, 7, pp.293~302 (2009)
- Fu Y, "Fermentation of ginseng extracts by Penicillium simplicissimum GS33 and anti-ovarian cancer activity of fermented products", World J Microbiol Biotechnol, 30, pp.1019~1025 (2014)
- Jung HJ, "Enhancement of anti-inflammatory and antinociceptive actions of red ginseng extract by fermentation", J Pharm Pharmacol, 64, pp.756~762 (2012)
- Roberts-Thomson IC, "Cells, cytokines and inflammatory bowel disease: a clinical perspective", Expert Rev Gastroenterol Hepatol, 5, pp.703~716 (2011)
- Schulzke JD, "Epithelial tight junctions in intestinal inflammation", Ann N Y Acad Sci, 1165, pp.294~300 (2009)
- Poritz LS, "Loss of the Tight Junction Protein ZO-1 in Dextran Sulfate Sodium Induced Colitis", J Surg Res, 140, pp.12~19 (2007)
- 권동주, "Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages", BMB Reports, 47(6), pp.318~323 (2014), 생화학분자생물학회
- Atreya I, "NF-kappaB in inflammatory bowel disease", J Intern Med, 263, pp.591~596 (2008)
- Ke F, "Herbal Medicine in the Treatment of Ulcerative Colitis", Saudi J Gastroenterol, 18, pp.3~10 (2012)
- Jin Y, "American ginseng suppresses inflammation and DNA damage associated with mouse colitis", Carcinogenesis, 29, pp.2351~2359 (2008)
- Hering NA, "Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics", J Physiol, 590, pp.1035~1044 (2012)
- Joh EH, "Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation", Biochem Pharmacol, 82, pp.278~286 (2011)
- Yang Hsu B, "Bioconversion of ginsenosides in the american ginseng(xi yang shen)extraction residue by fermentation with lingzhi(ling zhi, ganoderma lucidum)", J Tradit Complement Med, 3, pp.95~101 (2013)
- Park EK, "Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities", Int Arch Allergy Immunol, 133, pp.113~120 (2004)
- Li J, "Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation", PLoS One, 9, pp.e87810~ (2014)
- Bain CC, "Intestinal macrophages-specialised adaptation to a unique environment", Eur J Immunol, 41, pp.2494~2498 (2011)
- Mahida YR, "The key role of macrophages in the immunopathogenesis of inflammatory bowel disease", Inflamm Bowel Dis, 6, pp.21~33 (2000)
- Bischoff SC, "Intestinal permeability--a new target for disease prevention and therapy", BMC Gastroenterol, 14, pp.189~ (2014)
- Dijkstra G, "Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease?", Scand J Gastroenterol, pp.37~41 (2002)
- 남승택, "Role of NADH: quinone oxidoreductase-1 in the tight junctions of colonic epithelial cells", BMB Reports, 47(9), pp.494~499 (2014), 생화학분자생물학회
- Mishra SK, "Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium(DSS)-induced colitis in mice", J Ethnopharmacol, 143, pp.524~532 (2012)
- Lee SJ, "Chloroform fraction of Solanum tuberosum L. cv Jayoung epidermis suppresses LPS-induced inflammatory responses in macrophages and DSS-induced colitis in mice", Food Chem Toxicol, 63, pp.53~61 (2014)